Literature DB >> 27826153

Need for Formal Specialization in Pharmacy in Canada: A Survey of Hospital Pharmacists.

Jonathan Penm1, Neil J MacKinnon2, Derek Jorgenson3, Jun Ying4, Jennifer Smith5.   

Abstract

BACKGROUND: The Blueprint for Pharmacy was a collaborative initiative involving all of the major pharmacy associations in Canada. It aimed to coordinate, facilitate, and be a catalyst for changes required to align pharmacy practice with the health care needs of Canadians. In partial fulfilment of this mandate, a needs assessment for specialist certification for pharmacists was conducted.
OBJECTIVE: To conduct a secondary analysis of data from the needs assessment to determine the perceptions of hospital pharmacists regarding a formal certification process for pharmacist specialties in Canada.
METHODS: A survey was developed in consultation with the Blueprint for Pharmacy Specialization Project Advisory Group and other key stakeholders. It was distributed electronically, in English and French, to Canadian pharmacists identified through national and provincial pharmacy organizations (survey period January 15 to February 12, 2015). Data for hospital pharmacists were extracted for this secondary analysis. Multivariable logistic regression analyses were conducted to characterize those respondents who supported the certification process and those intending to become certified if a Canadian process were introduced.
RESULTS: A total of 640 responses were received from hospital pharmacists. Nearly 85% of the respondents (543/640 [84.8%]) supported a formal certification process for pharmacist specialization, and more than 70% (249/349 [71.3%]) indicated their intention to obtain specialty certification if a Canadian process were introduced. Respondents believed that the main barriers to developing such a system were lack of reimbursement models, the time required, and lack of public awareness of pharmacist specialties. They felt that the most important factors for an optimal certification process were a consistent definition of pharmacist specialty practice and consistent recognition of pharmacist specialty practice across Canada. Multiple regression analysis showed that female respondents were more likely to support a formal certification process (odds ratio [OR] 2.6, 95% confidence interval [CI] 1.2-5.7). Also, those who already specialized in pharmacotherapy were more likely to support mandatory certification (OR 2.6, 95% CI 1.1-6.1).
CONCLUSIONS: Hospital pharmacists who responded to this survey overwhelmingly supported certification for pharmacist specialization in Canada. Questions remain about the feasibility of establishing a pharmacist specialization system in Canada.

Keywords:  certification; hospital pharmacy; specialization; survey

Year:  2016        PMID: 27826153      PMCID: PMC5085320          DOI: 10.4212/cjhp.v69i5.1590

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  5 in total

1.  Should the provincial colleges of pharmacy create a category for "advanced practice pharmacist"?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2009-09

2.  Should all pharmacists responsible for pharmacotherapeutic management of patients with complex or special drug therapy needs have certification from the board of pharmacy specialties?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2012-05

3.  Does board certification really matter?

Authors:  Stuart T Haines
Journal:  Pharmacotherapy       Date:  2014-08       Impact factor: 4.705

4.  Credentialing and privileging of pharmacists: a resource paper from the Council on Credentialing in Pharmacy.

Authors: 
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Nov-Dec

5.  The effect of cardiovascular credentialed pharmacists on process measures and outcomes in myocardial infarction and heart failure.

Authors:  Michael P Dorsch; Jennifer M Lose; Robert J DiDomenico
Journal:  Pharmacotherapy       Date:  2014-06-05       Impact factor: 4.705

  5 in total
  1 in total

1.  Is it time for internal medicine pharmacists in primary care?

Authors:  Derek Jorgenson
Journal:  Can Pharm J (Ott)       Date:  2018-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.